Channel Wealth’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Channel Wealth’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-131,335	Closed	-$3.17M	–	214
2023 Q1	$3.17M	Buy	+131,335	New	+$1.65M	2.04%	5

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Channel Wealth's PRVB Position: Q2 2023 in Review

Channel Wealth sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 131,335 shares — an estimated $3.17M sold.

Channel Wealth first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $3.17M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Channel Wealth reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Channel Wealth sold 131,335 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $3.17M.
Channel Wealth first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Channel Wealth's Provention Bio, Inc. Common Stock position peaked at $3.17M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Channel Wealth's 13F filing for Q2 2023, filed 26 Jul 2023.